Latest Ziprasidone Stories
Vanda Pharmaceuticals has received a not approvable letter from the FDA in response to its new drug application for iloperidone, an investigational atypical antipsychotic that was reviewed for the treatment of schizophrenia.
By Gene Emery BOSTON (Reuters) - The first direct comparison of five schizophrenia drugs found that most newer treatments are no better than an older generic drug, despite their higher cost, a U.S. study released on Monday showed.
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.